These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 7970481)

  • 1. Reassessment of myometrial invasion in endometrial carcinoma.
    Kaku T; Tsuruchi N; Tsukamoto N; Hirakawa T; Kamura T; Nakano H
    Obstet Gynecol; 1994 Dec; 84(6):979-82. PubMed ID: 7970481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective evaluation of prognostic significance of the tumor-free distance from uterine serosa in surgically staged endometrial adenocarcinoma.
    Schwab KV; O'Malley DM; Fowler JM; Copeland LJ; Cohn DE
    Gynecol Oncol; 2009 Jan; 112(1):146-9. PubMed ID: 18937970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The significance of the amount of myometrial invasion in patients with Stage IB endometrial carcinoma.
    Alektiar KM; McKee A; Lin O; Venkatraman E; Zelefsky MJ; Mychalczak BR; McKee B; Hoskins WJ; Barakat RR
    Cancer; 2002 Jul; 95(2):316-21. PubMed ID: 12124832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-associated macrophages correlate with vascular space invasion and myometrial invasion in endometrial carcinoma.
    Soeda S; Nakamura N; Ozeki T; Nishiyama H; Hojo H; Yamada H; Abe M; Sato A
    Gynecol Oncol; 2008 Apr; 109(1):122-8. PubMed ID: 18289648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical value of intraoperative gross examination in endometrial cancer.
    Franchi M; Ghezzi F; Melpignano M; Cherchi PL; Scarabelli C; Apolloni C; Zanaboni F
    Gynecol Oncol; 2000 Mar; 76(3):357-61. PubMed ID: 10684710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Multivariate analysis of prognostic factors in endometrial carcinoma].
    Li B; Wu LY; Li SM; Zhang WH; Zhang R; Ma SK
    Ai Zheng; 2004 Sep; 23(9):1085-8. PubMed ID: 15363208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multivariate analysis of assessment of myometrial invasion of endometrial carcinoma by magnetic resonance imaging.
    Atsukawa H; Sasaki H; Tada S
    Gynecol Oncol; 1994 Sep; 54(3):298-306. PubMed ID: 8088606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion.
    Orezzoli JP; Sioletic S; Olawaiye A; Oliva E; del Carmen MG
    Gynecol Oncol; 2009 Jun; 113(3):316-23. PubMed ID: 19345400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of survival of surgically staged patients with endometrial carcinoma histologically confined to the uterus: implications for therapy.
    Kadar N; Malfetano JH; Homesley HD
    Obstet Gynecol; 1992 Oct; 80(4):655-9. PubMed ID: 1407890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peritumorous lymph-vascular invasion, grade of histologic differentiation, and myometrial infiltration as prognostic factors of endometrial carcinoma.
    De Góis NM; Martins NV; Abrão FS; De Lima GR; Alves AC
    Rev Paul Med; 1993; 111(3):385-90. PubMed ID: 8108630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour-free distance from serosa is a better prognostic indicator than depth of invasion and percentage myometrial invasion in endometrioid endometrial cancer.
    Chattopadhyay S; Galaal KA; Patel A; Fisher A; Nayar A; Cross P; Naik R
    BJOG; 2012 Sep; 119(10):1162-70. PubMed ID: 22804815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Difficulties in assessing the depth of myometrial invasion in endometrial carcinoma.
    Ali A; Black D; Soslow RA
    Int J Gynecol Pathol; 2007 Apr; 26(2):115-23. PubMed ID: 17413976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unusual epithelial and stromal changes in myoinvasive endometrioid adenocarcinoma: a study of their frequency, associated diagnostic problems, and prognostic significance.
    Murray SK; Young RH; Scully RE
    Int J Gynecol Pathol; 2003 Oct; 22(4):324-33. PubMed ID: 14501811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parametrial involvement in endometrial carcinomas: its incidence and correlation with other histological parameters.
    Yura Y; Tauchi K; Koshiyama M; Konishi I; Yura S; Mori T; Matsushita K; Hayashi M; Yoshida M
    Gynecol Oncol; 1996 Oct; 63(1):114-9. PubMed ID: 8898179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative assessment of deep myometrial and cervical invasion in endometrial carcinoma: comparison of magnetic resonance imaging and histopathologic evaluation.
    Vasconcelos C; Félix A; Cunha TM
    J Obstet Gynaecol; 2007 Jan; 27(1):65-70. PubMed ID: 17365463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The grading of lymphovascular space invasion in endometrial carcinoma.
    Hachisuga T; Kaku T; Fukuda K; Eguchi F; Emoto M; Kamura T; Iwasaka T; Kawarabayashi T; Sugimori H; Mori M
    Cancer; 1999 Nov; 86(10):2090-7. PubMed ID: 10570436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of tumor-free distance and depth of myometrial invasion as prognostic factors for lymph node metastases in endometrial cancer.
    Kondalsamy-Chennakesavan S; van Vugt S; Sanday K; Nicklin J; Land R; Perrin L; Crandon A; Obermair A
    Int J Gynecol Cancer; 2010 Oct; 20(7):1217-21. PubMed ID: 21495232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of gross myometrial invasion with endometrial cancer.
    Larson DM; Connor GP; Broste SK; Krawisz BR; Johnson KK
    Obstet Gynecol; 1996 Sep; 88(3):394-8. PubMed ID: 8752246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic significance of vascular invasion by endometrial carcinoma.
    Inoue Y; Obata K; Abe K; Ohmura G; Doh K; Yoshioka T; Hoshiai H; Noda K
    Cancer; 1996 Oct; 78(7):1447-51. PubMed ID: 8839550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased E-cadherin expression in endometrial carcinoma is associated with tumor dedifferentiation and deep myometrial invasion.
    Sakuragi N; Nishiya M; Ikeda K; Ohkouch T; Furth EE; Hareyama H; Satoh C; Fujimoto S
    Gynecol Oncol; 1994 May; 53(2):183-9. PubMed ID: 8188077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.